/ RecruitingNot Applicable ThermoBreast - Non-contact Breast Cancer Imaging Using AI-enhanced Thermography. An International, Multicenter, Prospective Development and Validation Trial.
Breast cancer is one of the most worrisome health concerns facing women. Early detection and active patient monitoring are crucial to survival. The chances of a cure are high when detected and treated in the early stages. Standard breast cancer diagnostic methods such as mammography, ultrasound, and MRI have limitations such as ionizing radiation, high false-positive rates, and/or high expenses.
Medical Thermography might overcome these limitations: It is a non-invasive , adjunctive physiologic imaging technology that uses a high-resolution infrared camera and computer processing to produce an image (thermogram) of a patient's skin surface temperatures. It is a non-contact screening method, which does not involve radiation exposure or invasive procedures, and is safe for both the patient and the trained personnel performing the screening. While mammography and ultrasound depend primarily on structural and anatomical variation of the tumor from the surrounding breast tissue, thermography detects pathophysiological changes within the breast such as metabolic and vascular changes caused by cancer. The heat transfer in the body is conducted by the circulatory system; hence, pathologies identified by thermography are generally associated with changes in blood perfusion.
To date, there has been no completed or ongoing large-scale, prospective, multicenter, international study that evaluates the diagnostic performance of thermal video streams coupled with advanced Artificial Intelligence algorithms for early-stage breast cancer screening and diagnosis. The proposed study will be crucial for the development of a new imaging modality that aims to be both cost-effective and to carry a minimal level of risk, facilitating screening of women of all age groups and breast densities, enabling early detection of abnormalities caused by malignant processes and improving patient monitoring.
100 Clinical Results associated with Univerzitetni Klinicni Center Ljubljana
0 Patents (Medical) associated with Univerzitetni Klinicni Center Ljubljana
The meaning of Covid-19 on the safety and health at work
Author: Pavlič, Miran ; Janež, Jasna ; Markič, Mirko ; Markič, Matej
01 Nov 2023·Journal of the American Society of Nephrology
Safety of Systemic Anticancer Treatment (ST) in Patients with ESKD and Metastatic Renal Cell Carcinoma (mRCC): A Single Institution Experience
Author: Seruga, Bostjan ; Arnol, Miha ; Jaimes, Edgar A. ; Milanez, Tomaz ; Ocvirk, Janja
01 Nov 2022·International Orthopaedics
Understanding consent for surgery and for treatment in orthopaedics
Author: Antolič, Vane ; Scarlat, Marius M
100 Deals associated with Univerzitetni Klinicni Center Ljubljana
100 Translational Medicine associated with Univerzitetni Klinicni Center Ljubljana